Clarification of Requirements Under the Food and Drug Regulations When Conducting Clinical Research With Cannabis
As more and more clinical trials are conducted utilizing Cannabis, these changes to the Canadian regulations are critical to be aware of. Join us to hear the details and be able to ask questions to the regulators. Dr Michael Leonard and Paul Smeaton from Health Canada will be speaking! Paul will start off by discussing the manufacturing, GMP, product impurities and other such issues with cannabis.
UPDATE: Paul had to cancel due to COVID illness. But that is ok, Michael will be there to discuss the clinical trial aspects of studies utilizing cannabis. It will be a very informative meeting.
Dr Michael P Leonard, MD, FRCSC
Manager, Office of Clinical Trials
Paul Smeaton
Manager, Clinical Trials Quality Division
Learning objectives:
- Develop a deeper understanding of the Food and Drug Regulations for cannabis clinical trials
- Discover the GMP issues with cannabis, including impurities
- Identify key points to help you with your cannabis clinical research
